Methylprednisolone Completed Phase 2 Trials for Myelodysplastic Syndrome / Aplastic Anemia Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00806598Thymoglobulin and Cyclosporine in Patients With Aplastic Anemia or Myelodysplastic Syndrome
NCT00004323Phase II Study of Bone Marrow Transplantation Using Related Donors in Patients With Aplastic Anemia